Expert suggestion for osteoporosis management during the recent COVID-19 pandemic

doi:10.16150/j.1671-2870.2022.02.005

Abstract

Abstract:

Osteoporosis is a chronic condition that reflects reduced bone strength and increased risk for fracture. As a chronic disease, osteoporosis generally requires sustained medical intervention to reduce the risks for bone loss, impaired bone integrity and fractures. The coronavirus disease 2019(COVID-19) pandemic has brought the unprecedented harmful effects on medical service,such as the cessation of osteoporosis therapies might be associated with an increased harm for bone health. The present expert suggestion provides recommendation for the management of osteoporotic patient during COVID-19, to help them safely return to routine clinical management.

Key words: COVID-19, Osteoporosis, Osteoporotic fracture, Anti-osteoporosis medication

CLC Number:

R589.5

Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for osteoporosis management during the recent COVID-19 pandemic[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 133-135.

References 12

[1]	Lv H, Zhang Q, Yin Y, et al. Epidemiologic characteristics of traumatic fractures during the outbreak of coronavirus disease 2019 (COVID-19) in China: A retrospective & comparative multi-center study[J]. Injury,2020, 51(8):1698-1704. doi: 10.1016/j.injury.2020.06.022 URL
[2]	中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华内分泌代谢杂志, 2017, 33(10):890-913.
	Osteoporosis and bone mineral Disease Branch of Chinese Medical Association. Diagnosis and treatment guidelines for primary osteoporosis(2017)[J]. Chin J Endocrinol Metab, 2017, 33(10):890-913.
[3]	Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome?[J]. Lancet Diabetes Endocrinol, 2020, 8(7):570. doi: 10.1016/S2213-8587(20)30183-2 URL
[4]	中国营养学会骨营养与健康分会, 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症患者的营养和运动管理专家共识[J]. 中华内分泌代谢杂志, 2020, 36(8):643-653.
	Bone nutrition and health branch of Chinese Nutrition Society, Osteoporosis and bone mineral Disease Branch of Chinese Medical Association. Expert consensus on nutrition and exercise management of patients with primary osteoporosis[J]. Chin J Endocrinol Metab, 2020, 36(8):643-653.
[5]	杨嫣琼, 张巧, 彭年春, 等. 睡眠时长、入睡时间与绝经后女性骨质疏松风险的相关性研究[J]. 中华内分泌代谢杂志, 2020, 36(11):949-955.
	Yang YQ, Zhang Q, Peng NC, et al. Study on the relationship between sleep duration, sleep time and the risk of osteoporosis in postmenopausal women[J]. Chin J Endocrinol Metab, 2020, 36(11):949-955.
[6]	Saag K, Lindsay R, Kriegman A, et al. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density[J]. Bone, 2007, 40(5):1238-1243. doi: 10.1016/j.bone.2007.01.016 URL
[7]	Rossini M, Adami S, Viapiana O, et al. Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration[J]. J Bone Miner Res, 2012, 27(1):227-230. doi: 10.1002/jbmr.521 URL
[8]	Zhu FC, Li YH, Guan XH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial[J]. Lancet, 2020, 395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3 URL
[9]	Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine[J]. N Engl J Med, 2021, 384(5):403-416. doi: 10.1056/NEJMoa2035389 URL
[10]	Reid IR, Gamble GD, Mesenbrink P, et al. Characterization of and risk factors for the acute-phase response after zoledronic acid[J]. J Clin Endocrinol Metab, 2010, 95(9):4380-4387. doi: 10.1210/jc.2010-0597 pmid: 20554708
[11]	Blanch-Rubió J, Soldevila-Domenech N, Tío L, et al. Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions[J]. Aging (Albany NY), 2020, 12(20):19923-19937.
[12]	Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension[J]. Lancet Diabetes Endocrinol, 2017, 5(7):513-523. doi: 10.1016/S2213-8587(17)30138-9 URL

[1]	SHI Feng, GUO Zhuying, GUO Haiyan. Clinical significance of changes in peripheral blood lymphocyte subsets in patients with novel coronavirus pneumonia [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 619-624.
[2]	LIU Xin, QI Caihui, WANG Zhenjing, LÜ Na, WANG Shaoting, WANG Shuping. Transcriptome study of glucagon like peptide-1 agonist Exendin-4 on mouse embryonic osteoblast precursor MC3T3-E1 in vitro [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 367-373.
[3]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestions on the management of hyperthyroidism and hypothyroidism in the time of COVID-19 [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 128-129.
[4]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for pituitary disease management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 130-132.
[5]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for diabetes management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 136-138.
[6]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for adrenal diseases management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 139-142.
[7]	CHEN Changqiang, MENG Jun, JIN Peipei, DAI Jing, et al . Practice and exploration of novel coronavirus nucleic acid detection in designated hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 143-149.
[8]	ZHUANG Lei, ZHENG Ruizhi, GAO Weiyi, et al . Analysis on the epidemic situation of COVID-19 by Omicron variant in a single office building [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 150-153.
[9]	ZHANG Feng, YANG Jing, YAN Yue, CHEN Weihong, CAI Zhengyu, LIU Xiying, CHENG Jie, WAN Jin, XI Jing, YANG Zhitao, QIU Liping, CHEN Erzhen. Analysis and suggestions on petition status of Fangcang and designated hospitals during COVID-19 epidemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 160-164.
[10]	ZHANG Yibo, WU Wenjuan, BI Yufang, JING Feng, GU Zhidong, YANG Zhitao, SHANG Hanbing, LIN Jingsheng, CHEN Erzhen. Construction and practice of infection prevention and control system in large Fangcang shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 165-168.
[11]	LOU Jiao, JIANG Lingli, WANG Yin, ZHOU Jing, HU Xiaobo, WANG Qing, et al . Exploration of quality control methods for regional COVID-19 nucleic acid detection laboratories [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 174-177.
[12]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[13]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[14]	. [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(01): 68-71.
[15]	. [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(02): 205-209.